biopharmaceutical

The six winners at the AstraZeneca’s R&D Postdoctoral Challenge awarded fully funded postdoctoral research positions at the company’s R&D centres

(PRESS RELEASE) CAMBRIDGE, 2-Nov-2022 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British-Swedish multinational pharmaceutical and biotechnology company, has announced fully…

2 years ago

Basilea Pharmaceutica Ltd secures non-dilutive refinancing from funds managed by Athyrium Capital Management, LP for its outstanding 2022 convertible bonds

Ad hoc announcement pursuant to Art. 53 LR (PRESS RELEASE) BASEL/ ALLSCHWIL, 7-Sep-2022 — /EuropaWire/ — Basilea Pharmaceutica Ltd (SWX:…

2 years ago

Almirall partners with Ablexis and AlivaMab Discovery Services to accelerate its development efforts for innovative treatment options for patients suffering from severe skin diseases

Through this license agreement with Ablexis, Almirall is granted rights to use the AlivaMab® Mouse technology for research, development, and…

2 years ago

AstraZeneca completes the transfer of Eklira/Tudorza and Duaklir global rights to Covis Pharma Group for $270 million

(PRESS RELEASE) CAMBRIDGE, 5-Jan-2021 — /EuropaWire/ — AstraZeneca (LON: AZN), a British-Swedish multinational pharmaceutical and biotechnology company, has announced the…

2 years ago

Covis Pharma takes over AstraZeneca’s COPD medicines Eklira and Duaklir for $270 million

Agreement sharpens AstraZeneca’s focus on priority medicines in Respiratory & Immunology portfolio (PRESS RELEASE) CAMBRIDGE, 1-Nov-2021 — /EuropaWire/ — AstraZeneca…

3 years ago

SGS adds 550m2 and 16 BSL-2 laboratories to its Glasgow biosafety testing facility

(PRESS RELEASE) GENEVA, 28-Oct-2021 — /EuropaWire/ — SGS, the world’s leading testing, inspection and certification company, has announced the expansion…

3 years ago

Sanofi gains full global rights to a promising antibody for inflammatory disorders with the acquisition of Kymab

(PRESS RELEASE) PARIS/ CAMBRIDGE, 11-Jan-2021 — /EuropaWire/ — French multinational pharmaceutical company Sanofi to acquire Kymab, a clinical-stage biopharmaceutical company…

3 years ago

Zeta Group and Siemens to work together for digital transformation of pharmaceutical processes

Strategic partnership for digital transformation of pharmaceutical processes Operational usage of digital plant data New Smart Engineering Services (SES) New…

4 years ago

ESMO Virtual Congress 2020: Libtayo positive pivotal data offer hope for the treatment of advanced basal cell carcinoma, a difficult-to-treat cancer

Libtayo is the first investigational medicine to show a clinical benefit in advanced basal cell carcinoma following treatment with a…

4 years ago

Sanofi tender offer for Principia Biopharma outstanding shares, August 28 – September 25, 2020

(PRESS RELEASE) PARIS, 28-Aug-2020 — /EuropaWire/ — French multinational pharmaceutical company Sanofi announces its intention to commence a tender offer…

4 years ago

Immune-mediated diseases biopharmaceutical Principia Biopharma Inc. acquired by Sanofi for approximately EUR 3.1 billion ($3.68 billion)

Further strengthens core R&D areas of autoimmune and allergic diseases Provides full control of brain-penetrant BTK inhibitor SAR442168 in multiple…

4 years ago

Alfa Laval introduces unique separator system for safer and more efficient biopharmaceutical processing

(PRESS RELEASE) LUND, 14-Apr-2020 — /EuropaWire/ — Alfa Laval announces the launch of a unique separator system, Alfa Laval CultureOne™,…

4 years ago

PDA GMP for APIs Education Webinar Now an “ICH Recognised Training Programme”

PDA met ICH's twelve eligibility criteria to gain recognition (PRESS RELEASE) BERLIN, 22-Nov-2019 — /EuropaWire/ — The Parenteral Drug Association…

4 years ago

ILC Dover to Open New Production Facility in Blarney, Ireland for Added Capabilities, Capacity and Jobs

Expansion positions ILC as leading single use powder handling solutions provider to the global pharma & biopharma market FREDERICA, DE,…

6 years ago

SGS to expand its biopharmaceutical testing capabilities in Geneva with a new 200m2 laboratory

GENEVA, 04-Sep-2018 — /EuropaWire/ — SGS, a leading bio/pharmaceutical analytical and bioanalytical contract solutions provider, today announced it is expanding…

6 years ago

John C. Reed, M.D. Ph.D. to succeed Elias Zerhouni, M.D. as Head of Global Research and Development at Sanofi

PARIS, 25-Apr-2018 — /EuropaWire/ — Elias Zerhouni, M.D., Head of Global Research and Development will retire from Sanofi on June…

6 years ago

Sanofi acquires Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders

Expands Sanofi’s presence in specialty care and strengthens leadership in rare diseases  Adds leader in the growing hemophilia market and…

6 years ago

200 healthcare decision-makers gather to address the looming challenges of cost, access and sustainability in the coming wave of high-value medicines

LONDON, 01-Dec-2017 — /EuropaWire/ — On December 5-6, 2017, 200 high-level experts from government, academia, biopharmaceutical developers and patient organisations…

6 years ago

SAVOR-TIMI-53 cardiovascular outcomes trial of ONGLYZA® results announced by AstraZeneca and Bristol-Myers Squibb

20-6-2013 — /europawire.eu/ — AstraZeneca and Bristol-Myers Squibb announced today top-line results of the Phase IV SAVOR-TIMI-53 (Saxagliptin Assessment of Vascular…

11 years ago